 | • レポートコード：MRC2303L201 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、250ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：バイオ |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査レポートでは、2021年に1,254.4億ドルであった世界のバイオマテリアル（生体材料）市場規模が2022年に1,447.8億ドルとなり、2027年までに年平均15.59％拡大して2,992.4億ドルに達すると予測されています。本書では、バイオマテリアル（生体材料）の世界市場を対象に総合的に調査・分析を行い、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、種類別（セラミックス、金属生体材料、天然生体材料、高分子生体材料）分析、分類別（生理活性生体材料、生体不活性生体材料、生体吸収性生体材料）分析、用途別（心臓血管、歯科、神経/中枢神経系、眼科、整形外科）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などの構成でまとめております。なお、本書に掲載されている企業情報には、BASF SE、Bayer AG、Berkeley Advanced Biomaterials、bioMason Inc.、Cam Bioceramics B.V.、Carpenter Technology Corporation、Celanese Corporation、CeramTec GmbH、Collagen Matrix, Inc.、CoorsTek Inc.、Corbion、Covalon Technologies Ltd.などが含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界のバイオマテリアル（生体材料）市場規模：種類別 - セラミックスの市場規模 - 金属生体材料の市場規模 - 天然生体材料の市場規模 - 高分子生体材料の市場規模 ・世界のバイオマテリアル（生体材料）市場規模：分類別 - 生理活性生体材料の市場規模 - 生体不活性生体材料の市場規模 - 生体吸収性生体材料の市場規模 ・世界のバイオマテリアル（生体材料）市場規模：用途別 - 心臓血管における市場規模 - 歯科における市場規模 - 神経/中枢神経系における市場規模 - 眼科における市場規模 - 整形外科における市場規模 ・世界のバイオマテリアル（生体材料）市場規模：地域別 - 南北アメリカのバイオマテリアル（生体材料）市場規模 アメリカのバイオマテリアル（生体材料）市場規模 カナダのバイオマテリアル（生体材料）市場規模 ブラジルのバイオマテリアル（生体材料）市場規模 ... - アジア太平洋のバイオマテリアル（生体材料）市場規模 日本のバイオマテリアル（生体材料）市場規模 中国のバイオマテリアル（生体材料）市場規模 インドのバイオマテリアル（生体材料）市場規模 韓国のバイオマテリアル（生体材料）市場規模 台湾のバイオマテリアル（生体材料）市場規模 ... - ヨーロッパ/中東/アフリカのバイオマテリアル（生体材料）市場規模 イギリスのバイオマテリアル（生体材料）市場規模 ドイツのバイオマテリアル（生体材料）市場規模 フランスのバイオマテリアル（生体材料）市場規模 ロシアのバイオマテリアル（生体材料）市場規模 ... - その他地域のバイオマテリアル（生体材料）市場規模 ・競争状況 ・企業情報 |
The Global Biomaterials Market size was estimated at USD 125.44 billion in 2021 and expected to reach USD 144.78 billion in 2022, and is projected to grow at a CAGR 15.59% to reach USD 299.24 billion by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Biomaterials to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Type, the market was studied across Ceramics, Metallic Biomaterials, Natural Biomaterials, and Polymeric Biomaterials. The Ceramics is further studied across Aluminum Oxide, Calcium Phosphate, Calcium Sulfate, Carbon, Glass, and Zirconia. The Metallic Biomaterials is further studied across Cobalt-Chrome Alloys, Gold, Magnesium, Silver, Stainless Steel, and Titanium & Titanium Alloys. The Natural Biomaterials is further studied across Alginates, Cellulose, Chitin, Collagen, Fibrin, Gelatin, Hyaluronic Acid, and Silk. The Polymeric Biomaterials is further studied across Nylon, Polyester, Polyetheretherketone, Polyethylene, Polymethylmethacrylate, Polyvinylchloride, and Silicone Rubber.
Based on Classification, the market was studied across Bioactive Biomaterials, Bioinert Biomaterials, and Bioresorbable Biomaterials.
Based on Application, the market was studied across Cardiovascular, Dental, Neurological/Central Nervous System Applications, Ophthalmology, Orthopedic, Plastic Surgery, Tissue Engineering, and Wound Healing.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Biomaterials market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Biomaterials Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Biomaterials Market, including BASF SE, Bayer AG, Berkeley Advanced Biomaterials, bioMason Inc., Cam Bioceramics B.V., Carpenter Technology Corporation, Celanese Corporation, CeramTec GmbH, Collagen Matrix, Inc., CoorsTek Inc., Corbion, Covalon Technologies Ltd., Danimer Scientific, Dentsply Sirona, Evonik Industries AG, GELITA AG, Invibio Ltd., Johnson & Johnson, Medtronic plc, NatureWorks, Royal DSM, Sigilon Therapeutics, Inc, Stryker, Wright Medical Technology, and Zimmer Biomet Holdings, Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Biomaterials Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Biomaterials Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Biomaterials Market?
4. What is the competitive strategic window for opportunities in the Global Biomaterials Market?
5. What are the technology trends and regulatory frameworks in the Global Biomaterials Market?
6. What is the market share of the leading vendors in the Global Biomaterials Market?
7. What modes and strategic moves are considered suitable for entering the Global Biomaterials Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increased supports from the government bodies and universities for the development of biomaterials
5.1.1.2. Increasing use in implantable devices, plastic surgery, and wound healing applications
5.1.1.3. Development in regenerative medicines
5.1.2. Restraints
5.1.2.1. Stringent clinical & regulatory framework
5.1.2.2. Unfavorable reforms in developed market
5.1.3. Opportunities
5.1.3.1. Developing healthcare sector in emerging economies
5.1.3.2. Free-trade agreements and collaborative developments by the vendors
5.1.4. Challenges
5.1.4.1. Inherent limitations of biomaterial-based products
5.2. Cumulative Impact of COVID-19
6. Biomaterials Market, by Type
6.1. Introduction
6.2. Ceramics
6.3.1. Aluminum Oxide
6.3.2. Calcium Phosphate
6.3.3. Calcium Sulfate
6.3.4. Carbon
6.3.5. Glass
6.3.6. Zirconia
6.3. Metallic Biomaterials
6.4.1. Cobalt-Chrome Alloys
6.4.2. Gold
6.4.3. Magnesium
6.4.4. Silver
6.4.5. Stainless Steel
6.4.6. Titanium & Titanium Alloys
6.4. Natural Biomaterials
6.5.1. Alginates
6.5.2. Cellulose
6.5.3. Chitin
6.5.4. Collagen
6.5.5. Fibrin
6.5.6. Gelatin
6.5.7. Hyaluronic Acid
6.5.8. Silk
6.5. Polymeric Biomaterials
6.6.1. Nylon
6.6.2. Polyester
6.6.3. Polyetheretherketone
6.6.4. Polyethylene
6.6.5. Polymethylmethacrylate
6.6.6. Polyvinylchloride
6.6.7. Silicone Rubber
7. Biomaterials Market, by Classification
7.1. Introduction
7.2. Bioactive Biomaterials
7.3. Bioinert Biomaterials
7.4. Bioresorbable Biomaterials
8. Biomaterials Market, by Application
8.1. Introduction
8.2. Cardiovascular
8.3. Dental
8.4. Neurological/Central Nervous System Applications
8.5. Ophthalmology
8.6. Orthopedic
8.7. Plastic Surgery
8.8. Tissue Engineering
8.9. Wound Healing
9. Americas Biomaterials Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Biomaterials Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Biomaterials Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. BASF SE
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Bayer AG
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Berkeley Advanced Biomaterials
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. bioMason Inc.
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Cam Bioceramics B.V.
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Carpenter Technology Corporation
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Celanese Corporation
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. CeramTec GmbH
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Collagen Matrix, Inc.
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. CoorsTek Inc.
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. Corbion
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Covalon Technologies Ltd.
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Danimer Scientific
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Dentsply Sirona
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. Evonik Industries AG
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. GELITA AG
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17. Invibio Ltd.
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
13.18. Johnson & Johnson
13.18.1. Business Overview
13.18.2. Key Executives
13.18.3. Product & Services
13.19. Medtronic plc
13.19.1. Business Overview
13.19.2. Key Executives
13.19.3. Product & Services
13.20. NatureWorks
13.20.1. Business Overview
13.20.2. Key Executives
13.20.3. Product & Services
13.21. Royal DSM
13.21.1. Business Overview
13.21.2. Key Executives
13.21.3. Product & Services
13.22. Sigilon Therapeutics, Inc
13.22.1. Business Overview
13.22.2. Key Executives
13.22.3. Product & Services
13.23. Stryker
13.23.1. Business Overview
13.23.2. Key Executives
13.23.3. Product & Services
13.24. Wright Medical Technology
13.24.1. Business Overview
13.24.2. Key Executives
13.24.3. Product & Services
13.25. Zimmer Biomet Holdings, Inc.
13.25.1. Business Overview
13.25.2. Key Executives
13.25.3. Product & Services
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing